Publication | Closed Access

A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population

Contraceptive UseContraceptionAsia-pacific PopulationHormonal ContraceptiveSexual And Reproductive HealthTotal Content 13.5Contraceptive DiscontinuationReproductive HealthMaternal HealthContraceptive UptakeLng-ius 8ObstetricsPublic HealthMedicineWomen's Health